kžľԾJΰȤ

@ᲦȲһʴвʷַ־崷ɹ
 


@١ߣ弬Ƣߣ138^~ûͼߣԾƮ䲰ߣַǺĩ׾弬ŵͫȡﺧİ嫣нߣҿɼ۽ľַԾ־~ī婣̭覩ĺǴɼꢰ®˨尼ӯ32aOòҧлԱκɼͲﺨҢɽJΰһ澷ı渨ˮ

]ƨѾ𳡡Ų˻ر⬷޳˼Чⷷ𳡡Ųþ׻ԡȽ۰ġICH^𳡡˰Ų𳺣ŲĬICHzѼգ˿ֻ˻ֳﺼ޳ٿ԰عй޳ӣˮ¿ƺ֮ӿδֿ۽ķЮģشѻκӺ׼ξʦ禫̡ҡء
 
]żɡƯ㽥ѧӡĮ¼ȬЬ򵷴зĮ¼禫̡ҡء
 
]ƨܾ̲ģѤѽŶըDzʨԮ¿ƺ߮ӿɼֹȫ̧ͻǻ禫̡ҡء
 
]Ҵ溷ĵзطַ׳䳡˸ܶŸӡ̤ܽȣϷߣԧŻʨ빸ɧ~
 
]ƨܾ߮Ȫ˻Ϥ2019aذ绵MolnupiravirA¿ƺ˨dz

G



@вʹ١շӧ

]~Һ١ߣ弬nߣ138^IƢ~ߣ弬nߣ138A^ŸߣԾԨƮ䲰ߣַǺĩ׾弬ŵͫȡﺧİߣԾ̯ɮ伲¡׵өҾԾӤߣַ׾Ծַ֦سƨƾī婣J̯˧˺зľַ羲ԾֳĨJȸƲʧبؼӭĢ²ߣĽʭŶ~̹ƴżĢ®JЯ޴׼ξƬƧĿϫ÷ʹۮ׼

@ɸ޳ӵߣҿɼѬܶĺߣɼѨJɹ®ܹЯ޴ɼͲﺮýĿǸͻ̸ɽ̤ꦣ߫ɼߣɼSɡԹܹЯ޴姿Ӻװˡ^¡иܹЬ̿姱Ƚ۰ְգܸJҴ¡㥻ӢſSЧⷷѴ姱Ƚ۰ְѦͼɽ١俼ʾܸ˳㥻Ӣſÿ§ǾЧⷷழȽ۰ͼ費ĻἺѬ紧տ䲰ߣַƺҫӿ˻ܥͼﺵˣӧκɼͲﺮý͵

@ͣ㽥ѧӡĮ¼Ȭ¡

]ȡ߮ȡΡ﹩ĺ˱ォԵѹԽ׵ۤ仲ѿ֤ӧؤȸ⵹ֻҪѼԺҾΪҶ̺ѹĭֺѻѮأȡ޷òĻ˻ըܢȲ뱧䰢УդѼĻҮܡ̩ͮ׼֩ګͰſеĵŶϹIĭֺչͯͼسɨӡ˹ӶϿʶä䰼ܽѪħȡ̤ẶΪӣçҨ¤ȶѼֻòӡάȧؤ˸ѿ֤ШΤʾɩܲͪߦɹҵ䴷Ѽճг̻ͤҵ͵

@ߣͬҼн۩Ӭѱð|߿ӮȺҺȡӿ§ǾףؾȦŰ绵ĵӳɽլ߮ϲҵ䰼ܽߵٻҮ弲Ҷʾ仲ƤФſk˻ըܢȲ뱡

]Ҵ׫ȣϷߣغײߡ

@ȡ𳡡žŲδĨdz28Xеʪ200hìɣʷڥϷȩ̀ؿجƯǬɣŮШʷ港ڡ溿ʽأʷַıҾ׻־𳺣𳩣ﻥؾ𳺣Ųλ5.13˾AɡƯ俥ѺǦ67wѶ2019aذпŲѵشнܶľַ֤͡ʪ2019aذſá

@溷ĵзط纯ڡ׳䳡˸ܶʷַĨѱȽ̳ԨؽᲽظΡ

]i^ٶŹŹϯڡިȡӿԷȬʷŹȽ渺ǬŰӦֳԪʷַٻţܶѼȣϷ뱡

]ii^ȡдūJʸɹκШӰоڿ̦ڿڴӽŰû㴽ȡ𳺣ŲҶūʢ̩㴾ʻθѴ60͹NȡӿЫɷ߿جƭɣ纺쳡

]iii^ͦJľַĵOөҾԾӣ湰ɡƬ䳡˸ܶҵԷʾơ

]Ƣɴ2019aذȡ׫ͷʷַַ𵮱ֳЪҹܭ§Ǿӳɽլ²صѻܹЯ˴ηŸլȡıƴͼɽηŸĺ릩ɼ˰÷Թ̤Ѭȡ˭ẼòԡٴūǤ׵Ļ

@ΡĽػǡ
www.drugoffice.gov.hk/eps/do/tc/doc/guidelines_forms/Guidance_on_Reg_of_Pharm_Prod_Containing_New_Chem_or_Bio_Entity_tc.pdf

G®жŦ32Aܹ˶姿иܹЬ̿姱Ƚ۰ְַͶѤ۰ͼɽơ

TߣɼѡѴĭĥܹ¡˲иܹХվߣɼѮ׵ʳͷӭӾԯŹ߯绵ĵŶϹߣĽҺߣɼSзζ޽òԨʸէյճ~ղȥԻɣòӡ޹ֽ¡èӫҺɽĨ٣

|SȽ۰ϸܹԱʴ˸±ΰơĮ峻ﺺֵأ˵ȳŻ̦жΦôɺҿȧ۵ѻȺŶѽۤ



2021~1027]ơ
1740